U.S. Senator Mike Crapo (R-Idaho), Ranking Member of the Senate Finance Committee, U.S. House Ways and Means Chair Jason Smith (R-Missouri) and U.S. House Energy and Commerce Chair Cathy McMorris Rodgers (R-Washington) are requesting detailed information from top government health officials regarding the $3 billion drug price-setting implementation fund included in the Inflation Reduction Act (IRA).
In a letter to Health and Human Services (HHS) Secretary Becerra and Centers for Medicare and Medicaid Services (CMS) Administrator Brooks-LaSure, the members note the partisan IRA directs a “baffling $3 billion to the implementation of misguided price controls,” but provides no reporting requirements or other safeguards with respect to the implementation funding.
Republicans assert that without proper oversight, the $3 billion fund will likely result in wasteful government expansion and bureaucratic bloat, raising program integrity, deficit reduction and good governance concerns.
The full letter can be found here.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and Microsoft Start.